StemoniX Information

View Top Employees from StemoniX

AxoSim, Inc. acquired the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary in October 2023. The microBrain™ technology provides a physiologically relevant human iPSC-derived screening platform for CNS drug discovery and toxicity testing. The organoid platform replicates important human CNS biology, containing cortical neurons and astrocytes that self-organize and form functional networks in 3D. The hallmark of the microBrain™ organoids is their remarkably consistent performance, making them ideal for high-throughput neurotoxicology, neuromodulation, and drug discovery investigations. For more information about microBrain™ contact sales@axosim.com

Website	https://axosim.com/acquisition/
Revenue	$6.8 million
Funding	$23.2 million
Employees	3 (1 on RocketReach)
Founded	2014
Address	13300 67th Ave N, Maple Grove, Minnesota 55311, US
Phone	+1 612-804-8225
Fax	(612) 977-8650
Technologies	JavaScript , HTML , Twitter +18 more (view full list)
Industry	Biotechnology Research, Business Services General, Biotechnology, Stem Cells, Business Services, Science and Engineering, Personalized Medicine, Health Diagnostics, Health Care
Web Rank	10 Million
Keywords	Drug Discovery Platform, Toxicity Testing, Stem Cell Technology, Preclinical Testing, Neuroscience Research, Central Nervous System, Drug Development, Disease Modeling, In Vitro Models, Cellular Assays, Biological Assays, In Vitro Toxicology, Biotechnology
Competitors	Synthego Corporation, CELLINK, Athersys, TissUse GmbH, MIMETAS, CureMetrix, Organovo Holdings, Inc., CorNeat Vision, InVivo Therapeutics, Vitanova +38 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies